亚洲最大福利网站_4hu四虎永久网址_麻豆国产原创_国产成人av一区二区

FDA approves Sanofi/Regeneron colon cancer drug
date:Aug 06, 2012
. The eye medicine has the same active ingredient as Zaltrap, called aflibercept, and is already achieving blockbuster sales and stealing market share from Roche's Lucentis treatment for the eye condition. Lucentis is derived from Avastin.
While near-term we expect (Regeneron's) stock will continue to trade primarily on the Eylea launch which remains impressive, we view Zaltrap's approval as a nice complement to what is rapidly becoming one of biotech's best commercial stories, Raymond said.
The

12/22 08:14